Ryan Kilpatrick

Head, Global Epidemiology - Abbvie

Kilpatrick is currently Vice President and Head of Global Epidemiology within the Pharmacovigilance and Patient Safety organization at AbbVie. He has over fifteen years of experience as a scientist and leader within the bio-pharmaceutical industry. Under his leadership, the Global Epidemiology organization leads the development, negotiation and conduct of post-marketing safety studiesand real-world evidence (RWE)aimed atevaluating the benefits and risks of AbbVie therapies, treatments and devices. 

Ryan Kilpatrick


  • Wednesday - November 24, 2021 - 16:00

    Safety as a strategy: Some current and emerging opportunities for pharmacoepidemiology and real-world evidence (RWE) generation to inform benefit/risk decision making

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now